These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12081228)

  • 21. High leptin levels are associated with stroke.
    Söderberg S; Stegmayr B; Ahlbeck-Glader C; Slunga-Birgander L; Ahrén B; Olsson T
    Cerebrovasc Dis; 2003; 15(1-2):63-9. PubMed ID: 12499713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Background of cardiovascular diseases in adult--with special reference to metabolic disorder of glucose and hypertension].
    Iimura O
    Nihon Ronen Igakkai Zasshi; 1994 Jan; 31(1):1-9. PubMed ID: 8158864
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of leptin in glucose metabolism in type 2 diabetes.
    Al-Daghri N; Bartlett WA; Jones AF; Kumar S
    Diabetes Obes Metab; 2002 May; 4(3):147-55. PubMed ID: 12047393
    [No Abstract]   [Full Text] [Related]  

  • 24. Conjugated linoleic acid deteriorates insulin resistance in obese/diabetic mice in association with decreased production of adiponectin and leptin.
    Ohashi A; Matsushita Y; Kimura K; Miyashita K; Saito M
    J Nutr Sci Vitaminol (Tokyo); 2004 Dec; 50(6):416-21. PubMed ID: 15895517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNFalpha expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis.
    Bulló M; García-Lorda P; Peinado-Onsurbe J; Hernández M; Del Castillo D; Argilés JM; Salas-Salvadó J
    Int J Obes Relat Metab Disord; 2002 May; 26(5):652-8. PubMed ID: 12032749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of selected interleukins, tumor necrosis factor, insulin and leptin in obese patients with hypertension].
    Bogdański P; Kujawska-Łuczak M; Łacki J; Pupek-Musialik D
    Pol Merkur Lekarski; 2003 Oct; 15(88):347-9; discussion 349-51. PubMed ID: 14974363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The glucoregulatory actions of leptin.
    D'souza AM; Neumann UH; Glavas MM; Kieffer TJ
    Mol Metab; 2017 Sep; 6(9):1052-1065. PubMed ID: 28951828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual effect of insulin on in vitro leptin secretion by adipose tissue.
    Casabiell X; Piñeiro V; De la Cruz LF; Gualillo O; Folgar L; Diéguez C; Casanueva FF
    Biochem Biophys Res Commun; 2000 Sep; 276(2):477-82. PubMed ID: 11027500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of leptin by agouti.
    Claycombe KJ; Xue BZ; Mynatt RL; Zemel MB; Moustaid-Moussa N
    Physiol Genomics; 2000 Apr; 2(3):101-5. PubMed ID: 11015588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential role of SH2-B and APS in regulating energy and glucose homeostasis.
    Li M; Ren D; Iseki M; Takaki S; Rui L
    Endocrinology; 2006 May; 147(5):2163-70. PubMed ID: 16455776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of diabetes, obesity and hypertension in type 2 diabetic KKAy mice by bis(allixinato)oxovanadium(IV) complex.
    Adachi Y; Yoshikawa Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H
    Biochem Biophys Res Commun; 2006 Jul; 345(3):945-50. PubMed ID: 16707105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenomic and metabolic responses of hypothalamic POMC neurons to gestational nicotine exposure in adult offspring.
    Silva JP; Lambert G; van Booven D; Wahlestedt C
    Genome Med; 2016 Sep; 8(1):93. PubMed ID: 27609221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of leptin actions in obesity: two concepts with cardiovascular implications.
    Mark AL; Correia ML; Rahmouni K; Haynes WG
    Clin Exp Hypertens; 2004; 26(7-8):629-36. PubMed ID: 15702617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain-mediated antidiabetic, anorexic, and cardiovascular actions of leptin require melanocortin-4 receptor signaling.
    da Silva AA; Spradley FT; Granger JP; Hall JE; do Carmo JM
    J Neurophysiol; 2015 Apr; 113(7):2786-91. PubMed ID: 25717164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leptin: a novel link between obesity, diabetes, cardiovascular risk, and ventricular hypertrophy.
    Sader S; Nian M; Liu P
    Circulation; 2003 Aug; 108(6):644-6. PubMed ID: 12912793
    [No Abstract]   [Full Text] [Related]  

  • 36. Resistant hypertension in diabetes mellitus.
    Bayliss G; Weinrauch LA; D'Elia JA
    Curr Diab Rep; 2014 Aug; 14(8):516. PubMed ID: 24965963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cutaneous gene therapy approach to human leptin deficiencies: correction of the murine ob/ob phenotype using leptin-targeted keratinocyte grafts.
    Larcher F; Del Rio M; Serrano F; Segovia JC; Ramírez A; Meana A; Page A; Abad JL; González MA; Bueren J; Bernad A; Jorcano JL
    FASEB J; 2001 Jul; 15(9):1529-38. PubMed ID: 11427484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity, diabetes, and leptin resistance promote tau pathology in a mouse model of disease.
    Platt TL; Beckett TL; Kohler K; Niedowicz DM; Murphy MP
    Neuroscience; 2016 Feb; 315():162-74. PubMed ID: 26701291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroinflammatory and autonomic mechanisms in diabetes and hypertension.
    Han C; Rice MW; Cai D
    Am J Physiol Endocrinol Metab; 2016 Jul; 311(1):E32-41. PubMed ID: 27166279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension in obesity: is leptin the culprit?
    Simonds SE; Cowley MA
    Trends Neurosci; 2013 Feb; 36(2):121-32. PubMed ID: 23333346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.